Antiphospholipid Syndrome (APS) is a major risk factor for pregnancy complications, yet diagnosing it remains challenging. Recent advancements in APS diagnostics provide deeper insights into its role in recurrent pregnancy loss and preeclampsia. Cutting-edge biomarker research and refined testing methods are improving accuracy, helping clinicians better identify at-risk patients and tailor treatment strategies. Discover the latest developments in APS diagnostics and their impact on maternal and fetal health.

A recent outbreak of Guillain-Barré Syndrome (GBS) in Pune, India, has seen approximately 160 reported cases since early January. The outbreak has been linked to Campylobacter jejuni, a foodborne pathogen and one of the leading causes of GBS worldwide [1]. Understanding Guillain-Barré Syndrome and Its Triggers GBS is a rare neurological autoimmune disease in which […]

Medipan & GA Generic Assays at the 14th International Congress on Autoimmunity in Ljubljana Some weeks ago, from May 17-19, 2024, we had the privilege of participating in the 14th International Congress on Autoimmunity in Ljubljana, Slovenia. This event brought together leading experts, researchers, and healthcare professionals to discuss the latest advancements in autoimmune diseases. […]

We’re pleased to announce a significant milestone with you all! Today marks our six-year participation anniversary in the prestigious Antinuclear Antibody (ANA) Survey, organized by the College of American Pathologists (CAP). Throughout these six years, our laboratory and our products have consistently demonstrated our commitment to excellence, navigating the intricacies of this well-known proficiency testing […]